ALIPURE
LIVE

Serial Number

85676136

Owner

ALZCHEM TROSTBERG GMBH

Attorney

Daniel M. Gurfinkel

Filing Date

Jul 13, 2012

Add to watchlist:

No watchlists yet
View on USPTO

ALIPURE Trademark

Serial Number: 85676136 • Registration: 4797545

ALIPURE is a trademark filed by ALZCHEM TROSTBERG GMBH on July 13, 2012. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 32 (Light Beverages). The application is currently registered and active.

Owner Contact Info

ALZCHEM TROSTBERG GMBH (57 trademarks)

TROSTBERG D-83308 , DE

Entity Type: 27

ALZCHEM AG (35 trademarks)

DR.-ALBERT-FRANK-STRASSE 32
TROSTBERG D-83308 , DE

Entity Type: 99

Trademark Details

Filing Date

July 13, 2012

Registration Date

August 25, 2015

Published for Opposition

June 9, 2015

Goods & Services

[ Preserved, frozen, dried, stewed and cooked fruits; preserved, frozen, dried, stewed and cooked vegetables; vegetarian food products, namely, vegetarian sausage, veggie burger patties, tofu, vegetable-based snack foods, vegetable based raw food bars; milk; milk products excluding ice cream, ice milk and frozen yogurt; whey; whey for use as a food, namely, whey powder and granulates; yoghurt; all of the aforementioned goods containing one or more of the following ingredients: sulfur-containing carbonic acids and their derivatives and salts, namely, alpha-lipoic acid, derivatives of alpha-lipoic acid, and salts of alpha-lipoic acid ]

[ Chemical products and preparations for medical, pharmaceutical, biopharmaceutical and medical diagnostic purposes, namely, chemical products and preparations for regeneration and recycling of antioxidant agents, for eliminating toxins from the body through decontamination and detoxification of humans and animals, for use as antioxidants, for use as complex and chelate building agents for eliminating toxins from the body, for use as a blood glucose lowering agent, and for neuropotective purposes in the treatment and diagnosis of neurological conditions; ] Chemical preparations [ for sanitary purposes and ] for use as dietary food Supplements; [ pharmaceutical products and preparations for the treatment and prevention of symptoms based on vitamin, amino acid, carbohydrate and trace elements deficiency, intoxication with heavy metals, radioactive metabolites and fungus poisoning, polyneuropathy, neurodegenerative disease, multiple sclerosis, cancer, diabetes, skin aging, arteriosclerosis, heart disease, liver disease or mitochondrial cytopathies; ] dietary food Supplements; food Supplements and Health food supplements intended for humans and animals for general health care purposes; dietary and nutritional Supplements; nutraceuticals for use as a dietary Supplement; [ whey protein supplements in the nature of whey powder and granulates; ] all of the aforementioned goods containing one or more of the following ingredients: sulfur-containing carbonic acids and their derivatives and salts, namely, alpha-lipoic acid, derivatives of alpha-lipoic acid, and salts of alpha-lipoic acid

[ Chemical preparations for general industrial manufacturing and for scientific purposes; chemical preparations for commercial purposes, namely, chemicals for use in industry; ] Chemical preparations for use in the food industry; Chemical additives for use in the manufacture of food; [ chemical preparations for use in the manufacture of pharmaceuticals and cosmetics; ] all of the aforementioned goods containing one or more of the following ingredients: sulfur-containing carbonic acids and their derivatives and salts, namely, alpha-lipoic acid, derivatives of alpha-lipoic acid, and salts of alpha-lipoic acid

[ Cosmetics and cosmetic preparations; cosmetic preparations for body care and skin care;all of the aforementioned goods containing one or more of the following ingredients: sulfur-containing carbonic acids and their derivatives and salts, namely, alpha-lipoic acid, derivatives of alpha-lipoic acid, and salts of alpha-lipoic acid ]

[ Confectionery, namely, yogurt-covered fruits, yogurt-covered nuts, yogurt-covered pretzels, peanut butter confectionery chips, frozen confections, frozen yogurt confections, fondants, crystal sugar pieces, confectionery made of sugar, chocolate confections; sweetmeats; candies; sugar; flour; preparations made from cereals, namely, breakfast cereals, processed cereals, and ready-to-eat cereals; bread; pastry; cookies; biscuits; cakes; cereal preparations, namely, breakfast cereals, processed cereals, and ready-to-eat cereals; cereal based snack foods; cereal bar, namely, high-protein cereal bars, cereal based energy bars, and ready to eat, cereal derived food bars; protein rich bar, namely, high-protein cereal bars; all of the aforementioned goods containing one or more of the following ingredients: sulfur-containing carbonic acids and their derivatives and salts, namely, alpha-lipoic acid, derivatives of alpha-lipoic acid, and salts of alpha-lipoic acid ]

[ Mineral and aerated waters; other non-alcoholic beverages, namely, coconut-based non-alcoholic beverages, kvass, carbonated beverages, non-alcoholic beverages containing fruit juices, non-alcoholic beverages with tea flavor, non-alcoholic fruit-juice beverages, non-alcoholic honey based beverages, non-alcoholic malt based beverages, soft drinks; lemonade; isotonic beverages; beverages for sportsmen and athletes, namely, sport drinks; fruit beverages and fruit juices; fruit nectars; syrups for making beverages; other preparations for making beverages, namely, concentrates and powders used in the preparation of energy drinks and fruit-flavored beverages, lemon juice for use in the preparation of beverages, non-alcoholic fruit extracts used in the preparation of beverages, powders used in the preparation of isotonic sports drinks and sports beverages, powders used in the preparation of fruit-based beverages; all of the aforementioned goods containing one or more of the following ingredients: sulfur-containing carbonic acids and their derivatives and salts, namely, alpha-lipoic acid, derivatives of alpha-lipoic acid, and salts of alpha-lipoic acid ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Nov 10, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 10, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 10, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 10, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
Jul 24, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 25, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 8, 2022 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 8, 2022 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 3, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 13, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 25, 2020 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 7, 2018 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 6, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2015 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 28, 2015 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 15, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 15, 2014 GNSL
SUSPENSION LETTER WRITTEN
Dec 15, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2014 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 4, 2014 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 9, 2014 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 9, 2014 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 9, 2014 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 30, 2014 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 25, 2013 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 25, 2013 GNSL
SUSPENSION LETTER WRITTEN
Nov 25, 2013 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 28, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 28, 2013 CRFA
ASSIGNED TO LIE
Oct 22, 2013 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 17, 2013 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2013 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 11, 2013 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 11, 2013 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 23, 2013 GNRN
NON-FINAL ACTION E-MAILED
Apr 23, 2013 GNRT
NON-FINAL ACTION WRITTEN
Apr 23, 2013 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 9, 2012 GNRN
NON-FINAL ACTION E-MAILED
Nov 9, 2012 GNRT
NON-FINAL ACTION WRITTEN
Nov 9, 2012 CNRT
ASSIGNED TO EXAMINER
Nov 6, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2012 NWOS
NEW APPLICATION ENTERED
Jul 17, 2012 NWAP